Homology Medicines, Inc.

We are mission-focused on developing
one-time treatments for genetic disorders

We are partners to the

rare disease community

Learn about our Clinical Trials >>>

We Are Applying our Broad Genetic Medicines

Platform to Treat, or Cure, Genetic Disease

Learn About Our Platform >>> View Our Pipeline >>>

Recent News >>>


March 15, 2023

Homology Medicines Announces Presentations on Design of Ongoing Gene Editing and Gene Therapy Trials for PKU and Hunter Syndrome at ACMG Annual Clinical Genetics Meeting

March 9, 2023

Homology Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights

March 9, 2023

Homology Medicines Announces Promotion of Julie Jordan, M.D., to Chief Medical Officer

We are

Homology

Learn about our Team and Mission >>>

Homology employee activities Homology employee activities
Homology employee activities Homology employee activities
Homology employee activities Homology employee activities
Homology Logo
  • We are Homology
    • We Are Homology
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Technology Platform
    • AAVHSC Platform
    • Gene Therapy
    • Gene Editing
    • GTx-mAb
    • Publications and Presentations
  • Pipeline
  • Patients & Families
    • Community Involvement
    • Patient Stories
      • Ava’s Story
      • Tia’s Story
    • Expanded Access Policy
  • Clinical Trials
    • Overview
    • Gene Editing Clinical Trial for PKU
    • Gene Therapy Clinical Trial for MPS II
  • Culture & Careers
  • Investors
    • Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Stock Calculator
    • News & Events
      • News Releases
      • Investor Calendar
      • Presentations
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor Resources
      • Email Alerts
      • Contact IR
  • Culture & Careers
  • Contact Us

© Copyright 2023 Homology Medicines, Inc. All rights reserved.

  • Terms of Use
  • Accessibility Statement
MENU
  • We are Homology
    • We Are Homology
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Technology Platform
    • AAVHSC Platform
    • Gene Therapy
    • Gene Editing
    • GTx-mAb
    • Publications and Presentations
  • Pipeline
  • Patients & Families
    • Community Involvement
    • Patient Stories
      • Ava’s Story
      • Tia’s Story
    • Expanded Access Policy
  • Clinical Trials
    • Overview
    • Gene Editing Clinical Trial for PKU
    • Gene Therapy Clinical Trial for MPS II
  • Culture & Careers
  • Investors
    • Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Stock Calculator
    • News & Events
      • News Releases
      • Investor Calendar
      • Presentations
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor Resources
      • Email Alerts
      • Contact IR